iKang Healthcare Group Inc (NASDAQ:KANG) was the target of a large decline in short interest in December. As of December 29th, there was short interest totalling 357,637 shares, a decline of 49.5% from the December 15th total of 707,528 shares. Based on an average trading volume of 288,908 shares, the days-to-cover ratio is presently 1.2 days. Approximately 0.5% of the shares of the stock are short sold.
Several research analysts have recently commented on the company. TheStreet raised iKang Healthcare Group from a “d+” rating to a “c” rating in a report on Friday, December 15th. BidaskClub raised iKang Healthcare Group from a “hold” rating to a “buy” rating in a report on Friday, December 22nd.
iKang Healthcare Group (NASDAQ KANG) opened at $15.80 on Friday. The company has a market capitalization of $1,086.07, a P/E ratio of 395.00 and a beta of 0.30. The company has a quick ratio of 0.78, a current ratio of 0.80 and a debt-to-equity ratio of 0.22. iKang Healthcare Group has a 1-year low of $11.70 and a 1-year high of $18.40.
Large investors have recently bought and sold shares of the business. Fosun International Ltd lifted its holdings in iKang Healthcare Group by 40.2% during the 3rd quarter. Fosun International Ltd now owns 3,571,138 shares of the medical research company’s stock worth $48,139,000 after buying an additional 1,023,199 shares in the last quarter. Pictet Asset Management Ltd. acquired a new position in iKang Healthcare Group during the 3rd quarter worth $330,000. Maso Capital Partners Ltd lifted its holdings in iKang Healthcare Group by 8.7% during the 3rd quarter. Maso Capital Partners Ltd now owns 1,504,062 shares of the medical research company’s stock worth $20,275,000 after buying an additional 120,655 shares in the last quarter. GLG Partners LP lifted its holdings in iKang Healthcare Group by 15.5% during the 2nd quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock worth $21,529,000 after buying an additional 235,056 shares in the last quarter. Finally, FIL Ltd lifted its holdings in iKang Healthcare Group by 45.4% during the 2nd quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock worth $4,429,000 after buying an additional 112,615 shares in the last quarter. 33.08% of the stock is currently owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION WARNING: “Short Interest in iKang Healthcare Group Inc (KANG) Decreases By 49.5%” was posted by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3144983/short-interest-in-ikang-healthcare-group-inc-kang-decreases-by-49-5.html.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.